alphaveSTAR₹1,211.00

Strides Pharma Science Ltd.

₹ CrorePeersSPARC SUPRIYA SHILPAMED THYROCARE RUBICON VIYASH YATHARTH PARKHOSPSMcap ₹11,162 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	878.7	880.7	992.4	992.4
+ Capital Work-in-Progress	79.9	99.6	161.1	161.1
+ Investment Property	11.9	11.2	0.2	0.2
+ Goodwill	529.4	546.6	594.4	594.4
+ Other Intangibles	445.1	460.9	513.5	513.5
+ Intangibles under Development	82.0	107.1	286.2	286.2
+ Investments (Equity Method)	189.3	10.7	12.5	12.5
+ Non-current Investments	7.6	329.0	278.9	278.9
+ Long-term Loans	50.0	0.0	0.0	0.0
+ Other Non-current Financial Assets	191.7	166.8	474.7	474.7
Non-current Financial Assets	249.3	495.8	753.5	753.5
+ Deferred Tax Assets	267.3	269.1	283.9	283.9
+ Other Non-current Assets	137.8	68.1	—	—
Total Non-current Assets	2,870.8	2,949.8	3,313.9	3,313.9
Current Assets
+ Inventories	1,126.2	1,277.6	1,634.8	1,634.8
+ Current Investments	105.8	69.5	0.0	0.0
+ Trade Receivables	1,141.9	1,202.9	1,289.0	1,289.0
+ Cash & Cash Equivalents	161.0	112.6	188.7	188.7
+ Other Bank Balances	30.1	24.2	24.4	24.4
+ Short-term Loans	12.7	10.4	8.1	8.1
+ Other Current Financial Assets	119.5	174.3	467.8	467.8
Current Financial Assets	1,571.0	1,594.0	1,978.0	1,978.0
+ Other Current Assets	271.7	227.4	270.5	270.5
Total Current Assets	2,969.0	3,098.9	3,612.8	3,612.8
Total Assets	5,839.8	6,048.7	6,927.2	6,927.2
Equity
+ Equity Share Capital	91.9	92.2	92.2	92.2
+ Other Equity / Reserves	2,033.7	2,459.7	3,015.4	3,015.4
Equity — Owners of Parent	2,125.6	2,551.8	3,107.6	3,107.6
+ Minority Interest	-53.9	34.6	41.8	41.8
Total Equity	2,071.7	2,586.5	3,149.3	3,149.3
Liabilities
+ Borrowings — Non-current	671.5	571.2	552.3	552.3
+ Other Non-current Financial Liab	85.3	66.2	83.1	83.1
Non-current Financial Liabilities	756.8	637.4	635.4	635.4
+ Provisions — Non-current	91.6	113.9	126.4	126.4
+ Deferred Tax Liabilities	40.3	119.4	120.7	120.7
Non-current Liabilities	888.8	870.7	882.4	882.4
+ Borrowings — Current	1,743.0	1,224.4	1,116.4	1,116.4
+ Trade Payables	851.6	1,032.5	1,309.7	1,309.7
+ Other Current Financial Liab	103.8	139.3	249.7	249.7
Current Financial Liabilities	2,698.4	2,396.2	2,675.8	2,675.8
+ Provisions — Current	71.5	81.2	96.4	96.4
+ Current Tax Liabilities	40.4	34.0	48.4	48.4
+ Other Current Liabilities	68.9	80.1	75.0	75.0
Current Liabilities	2,879.3	2,591.5	2,895.5	2,895.5
Total Liabilities	3,768.0	3,462.3	3,777.9	3,777.9
Total Equity & Liabilities	5,839.8	6,048.7	6,927.2	6,927.2
Assets — additional as-filed lines
+ Non-current Assets Held for Sale	0.0	0.0	0.5	0.5
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	31.9	46.4	46.4
+ Dues to Other Creditors — Current	—	1,000.6	1,263.3	1,263.3

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.